Navigating China’s IPO Options as STAR Becomes No-Go Zone

Yiming Liu, partner in charge of Cooley’s Shanghai office, was quoted by BioCentury regarding the regulatory policy changes to the China Securities Regulatory Commission that make the Shanghai STAR market a less desirable market for Chinese companies looking to list an initial public offering.

Read the article (subscription required)